Gary Headden to Biomarkers
This is a "connection" page, showing publications Gary Headden has written about Biomarkers.
Connection Strength
0.258
-
Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction. Circulation. 2020 10 20; 142(16):1532-1544.
Score: 0.117
-
Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome. Coron Artery Dis. 2022 08 01; 33(5):376-384.
Score: 0.033
-
Myocardial Infarction Can Be Safely Excluded by High-sensitivity Troponin I Testing 3 Hours After Emergency Department Presentation. Acad Emerg Med. 2020 08; 27(8):671-680.
Score: 0.029
-
Renal Function and Scaled Troponin in Patients Presenting to the Emergency Department with Symptoms of Myocardial Infarction. Am J Nephrol. 2017; 45(4):304-309.
Score: 0.023
-
Absolute and relative changes (delta) in troponin I for early diagnosis of myocardial infarction: Results of a prospective multicenter trial. Clin Biochem. 2015 Mar; 48(4-5):260-7.
Score: 0.019
-
Diagnostic performance of cardiac Troponin I for early rule-in and rule-out of acute myocardial infarction: Results of a prospective multicenter trial. Clin Biochem. 2015 Mar; 48(4-5):254-9.
Score: 0.019
-
Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol. 2013 Jul 09; 62(2):150-160.
Score: 0.018